Investigating the Therapeutic Effects of Albendazole, Mebendazole, and Praziquantel Nanocapsules in Hydatid Cyst-Infected Mice
Pathogens · 2025
DOI: 10.3390/pathogens14030240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Nooshinmehr Soleymani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad P.O. Box 9177948974, Iran. Hauptthemen laut MEDLINE: Praziquantel, Mebendazole, Echinococcosis, Nanocapsules. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the Ferdowsi University of Mashhad., Ferdowsi University of Mashhad.
Abstract (Originalsprache)
Drug resistance is the main challenge in treating parasitic diseases, including cystic echinococcosis (CE). Hence, the current study aims to investigate the effect of nanocapsules containing albendazole (ABZ), mebendazole (MBZ), and praziquantel (PZQ) on treating hydatid cysts in mice using these high-potency drugs. A total of 78 female white laboratory mice (BALB/C mice), 8 weeks old and weighing 25 g, were intraperitoneally injected with 1500 live protoscoleces of Echinococcus granulosus. The first group received ABZ nanocapsules, group 2 received MBZ nanocapsules, group 3 received PZQ nanocapsules, group 4 received ABZ + MBZ nanocapsules, group 5 received ABZ + PZQ nanocapsules, and group 6 received MBZ + PZQ nanocapsules. Each group also had a control group, which received the non-nanocapsulated drugs (group 7–12). Group 13 received no treatment and served as the negative control, just receiving phosphate-buffered saline (PBS). A thorough examination of the cysts’ physical properties, including size, quantity, and weight, was carried out. According to our results, the polymeric nanocapsules are sphere-like and of different sizes. The total number of cysts in all nanocapsule groups significantly decreased compared to the control group. In the total weight of the cysts, ABZ + MBZ nanocapsules, ABZ + PZQ nanocapsules, and MBZ + PZQ nanocapsules had the least total cyst weight, showing that the use of the medicinal combination had a better effect on the penetration and weight reduction of the cysts. In conclusion, the findings showed that ABZ, MBZ, and PZQ significantly reduced the size, weight, and number of hydatid cysts in the mouse model used in this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad P.O. Box 9177948974, Iran.
- WOAH and NRL for Echinococcosis, Animal Health, Istituto Zooprofilattico Sperimentale della Sardegna, 07100 Sassari, Italy.
- Department of Physics, University of Zabol, Zabol P.O. Box 53898615, Iran.
ORCID-Profile: Soheil Sadr, Cinzia Santucciu, Abbas Rahdar, Hassan Borji
Förderung
- This research was funded by the Ferdowsi University of Mashhad.
- Ferdowsi University of Mashhad
Zitieren
APA
Soleymani, N., Sadr, S., Santucciu, C., Rahdar, A., Masala, G., & Borji, H. (2025). Investigating the Therapeutic Effects of Albendazole, Mebendazole, and Praziquantel Nanocapsules in Hydatid Cyst-Infected Mice. Pathogens. https://doi.org/10.3390/pathogens14030240
Vancouver
Soleymani N, Sadr S, Santucciu C, Rahdar A, Masala G, Borji H. Investigating the Therapeutic Effects of Albendazole, Mebendazole, and Praziquantel Nanocapsules in Hydatid Cyst-Infected Mice. Pathogens. 2025. doi:10.3390/pathogens14030240
BibTeX
@article{Soleymani2025,
author = {Soleymani, Nooshinmehr and Sadr, Soheil and Santucciu, Cinzia and Rahdar, Abbas and Masala, Giovanna and Borji, Hassan},
title = {Investigating the Therapeutic Effects of Albendazole, Mebendazole, and Praziquantel Nanocapsules in Hydatid Cyst-Infected Mice},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14030240}
}
EUVIMED